Showing results (11-20 of 288) with videos related to

Sort By:
Pageof 29
Health Economics|August 3, 2021
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systemsBeth Woods, Aimée Fox, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further ResearchBeth Woods, Paul Revill, Mark Sculpher, et al.
Health Economics|December 10, 2014
Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?Karl Claxton, Mark Sculpher, Stephen Palmer, et al.
Health Economics|October 5, 2017
Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health systemManuel Antonio Espinoza, Andrea Manca, Karl Claxton, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Efficiency, equity, and budgetary policies: informing decisions using mathematical programmingDavid M Epstein, Zaid Chalabi, Karl Claxton, et al.
Health Economics|February 1, 2020
Distributional cost effectiveness analysis of West Yorkshire low emission zone policiesSusan Griffin, Simon Walker, Mark Sculpher
Pharmacoeconomics|April 12, 2006
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessmentZoë Philips, Laura Bojke, Mark Sculpher, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 31, 2009
Exploring the research decision space: the expected value of information for sequential research designsSusan Griffin, Nicky J Welton, Karl Claxton
Health Economics|January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments requiredBeth Woods, James Lomas, Mark Sculpher, et al.
Journal of Clinical Epidemiology|September 22, 2015
Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injuryClaire McKenna, Susan Griffin, Hendrik Koffijberg, et al.
Pageof 29